CASI Pharmaceuticals (CASIF) Cash & Equivalents (2021 - 2026)
CASI Pharmaceuticals' Cash & Equivalents came in at $3.77 million for Q2 2026, down 44.1% from $6.74 million a year earlier.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, CASI Pharmaceuticals' Cash & Equivalents was $5.63 million, down 58.2% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -36.3% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $13.47 million in FY2024 (-100.0%), $47.11 trillion in FY2023 (+21.7%), $38.7 trillion in FY2022 (-32.2%) and $57.06 trillion in FY2021.
- The Q2 2026 figure represents the lowest quarterly Cash & Equivalents in data going back to Q4 2021.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2023 (growth of 21.7%), and the weakest in Q4 2024 (a decline of 100.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | CASI Pharmaceuticals | 2.47 Mn | -18.36 Mn | - | 3.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.77 Mn |
| Dec 31, 2025 | 5.63 Mn |
| Sep 30, 2025 | 4.69 Mn |
| Jun 30, 2025 | 6.74 Mn |
| Mar 31, 2025 | 10.90 Mn |
| Dec 31, 2024 | 13.47 Mn |
| Jun 30, 2024 | 9.53 Mn |
| Mar 31, 2024 | 12.20 Mn |
| Dec 31, 2023 | 47,112.00 Bn |
| Sep 30, 2023 | 19.98 Mn |
| Jun 30, 2023 | 16.92 Mn |
| Mar 31, 2023 | 16.59 Mn |
| Dec 31, 2022 | 38,704.00 Bn |
| Dec 31, 2021 | 57,064.00 Bn |
API Access
CASI Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();